You need to upgrade your Flash Player
$0.42 (0.85%)
06:21PM (15 mins delay)
| Today | 5d | 1m | 3m | 1y | 5y | 10y |
| Last: | $50.05 | High: | - |
| Prev Close: | $49.63 | Low: | - |
| Open: | - | Mkt Cap: | $13.17B |
| Change: | $0.42 ( 0.85% ) | 52Wk High: | $73.75 |
| Vol: | 0 | 52Wk Low: | $47.09 |
| Avg Volume: | 4,117,524 | Shares: | N/A |
| EPS: | - | PE Ratio: | 28.36 |
A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, diagnostic & predictive testing and cancer.
|
John Lansing
via Twitter |
Nov 03 2:59 PM |
|
$GENZ plant gets OK from European regulators http://bit.ly/2I4ZuI
Comment |
||
|
Elliott Wave
via Twitter |
Oct 26 11:32 AM |
|
$($GENZ) - If price can continue the recovery off this week's low, go long at 57.00 with a target at 61.00$$
Comment |
||
|
|
Elliott Wave
via Twitter |
Oct 26 11:30 AM |
|
$($GENZ) - If price can continue the recovery off this week's
low, go long at 57.00 with a target at 61.00
Comment |
||
|
Jason Christensen
via Twitter |
Oct 23 11:14 AM |
|
@stockgod my feeling on $CYCC drug is good, but FDA always gets picky with these look at $VION or $GENZ similar drugs
Comment |
||
Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.
|
||||||||||||||||||||||||||||||
© 2009 UpDown. All Rights Reserved.
Make a suggestion for this page
Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.
